Das Wallstreet Journal beklagt die Verfälschung von Forschungsergebnissen durch die Interessen der Pharmaindustrie:
65% of 122 articles published last year in JAMA did not completely report harmful drug effects and 50% of the articles had gaps in the over all effectiveness of the drug.
In: New Protocol: Worrisome Ailment in Medicine: Misleading Journal Articles; Editors Demand More Data To Ensure Full Disclosure of Drug Risks, Trial Gaps; Sarbanes-Oxley for Professors (Nur für Subscriber), by Anna Wilde Mathews Wall Street Journal May 10, 2005 pg. A1. [via Krafty Librarian (hier weitere Auszüge)]